Birch Grove Capital LP - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAA4. A total of 29 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Birch Grove Capital LP ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$7,206,000
-3.5%
7,424,0000.0%3.24%
+9.2%
Q3 2018$7,467,000
-3.7%
7,424,0000.0%2.97%
-20.7%
Q2 2018$7,757,000
-1.8%
7,424,0000.0%3.74%
-9.6%
Q1 2018$7,901,000
+6.4%
7,424,0000.0%4.14%
-8.9%
Q4 2017$7,424,000
-5.9%
7,424,0000.0%4.54%
-7.2%
Q3 2017$7,888,000
+1.8%
7,424,0000.0%4.89%
+4.8%
Q2 2017$7,748,000
-45.2%
7,424,000
-25.8%
4.66%
-62.4%
Q4 2016$14,144,000
-27.8%
10,000,000
-42.0%
12.41%
-32.5%
Q3 2016$19,597,000
+2.4%
17,250,0000.0%18.38%
+82.5%
Q2 2016$19,146,00017,250,00010.07%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
STEELHEAD PARTNERS LLC 42,500,000$43,297,0003.73%
Mohican Financial Management, LLC 6,000,000$6,056,0002.34%
GRACE BROTHERS MANAGEMENT LLC 1,750,000$1,781,0001.66%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 34,520,000$34,986,0001.43%
SILVERBACK ASSET MANAGEMENT LLC 12,250,000$12,472,0000.88%
Man Investments (CH) AG 1,800,000$1,845,0000.74%
SCHRODER INVESTMENT MANAGEMENT GROUP 5,000,000$510,380,000,0000.58%
WOLVERINE ASSET MANAGEMENT LLC 21,109,000$21,536,0000.46%
Wellesley Asset Management 6,611$6,707,0000.43%
DINSMORE CAPITAL MANAGEMENT CO/NJ 1,000,000$1,013,0000.40%
View complete list of AMAG PHARMACEUTICALS INC shareholders